vs
CANTALOUPE, INC.（CTLP）与Vericel Corp（VCEL）财务数据对比。点击上方公司名可切换其他公司
Vericel Corp的季度营收约是CANTALOUPE, INC.的1.2倍（$92.9M vs $78.7M），Vericel Corp净利率更高（25.0% vs -0.1%，领先25.1%），Vericel Corp同比增速更快（23.3% vs 6.8%），Vericel Corp自由现金流更多（$12.8M vs $-614.0K），过去两年Vericel Corp的营收复合增速更高（34.6% vs 7.7%）
坎塔卢波（原美国技术公司）是一家美国科技企业，核心业务为ePort无现金支付受理技术，依托持专利的PCI合规ePort Connect服务开展运营。该服务可通过无线方式为消费者提供信用卡、借记卡以及Apple Pay、Google Pay等NFC钱包支付选项，同时为运营商提供遥测与机器间通信服务，ePort技术主要应用于...
Vericel Corp是一家美国上市生物制药企业，前身为1989年在密歇根州安娜堡成立的Aastrom Bio，2014年10月正式更为现名，专注于生物制药相关领域的研发与商业化运营。
CTLP vs VCEL — 直观对比
营收规模更大
VCEL
是对方的1.2倍
$78.7M
营收增速更快
VCEL
高出16.5%
6.8%
净利率更高
VCEL
高出25.1%
-0.1%
自由现金流更多
VCEL
多$13.4M
$-614.0K
两年增速更快
VCEL
近两年复合增速
7.7%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $78.7M | $92.9M |
| 净利润 | $-70.0K | $23.2M |
| 毛利率 | — | 78.7% |
| 营业利润率 | 2.0% | 24.1% |
| 净利率 | -0.1% | 25.0% |
| 营收同比 | 6.8% | 23.3% |
| 净利润同比 | -101.4% | 17.3% |
| 每股收益（稀释后） | $0.00 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTLPVCEL
| Q4 25 | $78.7M | $92.9M | ||
| Q3 25 | $80.9M | $67.5M | ||
| Q2 25 | $82.6M | $63.2M | ||
| Q1 25 | $75.4M | $52.6M | ||
| Q4 24 | $73.7M | $75.4M | ||
| Q3 24 | $70.8M | $57.9M | ||
| Q2 24 | $72.7M | $52.7M | ||
| Q1 24 | $67.9M | $51.3M |
净利润CTLPVCEL
| Q4 25 | $-70.0K | $23.2M | ||
| Q3 25 | $-919.0K | $5.1M | ||
| Q2 25 | $6.8M | $-553.0K | ||
| Q1 25 | $49.2M | $-11.2M | ||
| Q4 24 | $5.0M | $19.8M | ||
| Q3 24 | $3.6M | $-901.0K | ||
| Q2 24 | $2.2M | $-4.7M | ||
| Q1 24 | $4.7M | $-3.9M |
毛利率CTLPVCEL
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | 39.6% | 68.9% |
营业利润率CTLPVCEL
| Q4 25 | 2.0% | 24.1% | ||
| Q3 25 | 2.0% | 5.1% | ||
| Q2 25 | 6.3% | -3.2% | ||
| Q1 25 | 9.1% | -24.3% | ||
| Q4 24 | 8.4% | 24.5% | ||
| Q3 24 | 5.8% | -4.3% | ||
| Q2 24 | 4.9% | -11.5% | ||
| Q1 24 | 6.3% | -10.7% |
净利率CTLPVCEL
| Q4 25 | -0.1% | 25.0% | ||
| Q3 25 | -1.1% | 7.5% | ||
| Q2 25 | 8.3% | -0.9% | ||
| Q1 25 | 65.2% | -21.4% | ||
| Q4 24 | 6.7% | 26.3% | ||
| Q3 24 | 5.0% | -1.6% | ||
| Q2 24 | 3.0% | -8.9% | ||
| Q1 24 | 6.9% | -7.5% |
每股收益（稀释后）CTLPVCEL
| Q4 25 | $0.00 | $0.46 | ||
| Q3 25 | $-0.02 | $0.10 | ||
| Q2 25 | $0.10 | $-0.01 | ||
| Q1 25 | $0.65 | $-0.23 | ||
| Q4 24 | $0.07 | $0.40 | ||
| Q3 24 | $0.04 | $-0.02 | ||
| Q2 24 | $0.03 | $-0.10 | ||
| Q1 24 | $0.06 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $53.0M | $137.5M |
| 总债务越低越好 | $37.7M | — |
| 股东权益账面价值 | $252.5M | $354.6M |
| 总资产 | $381.9M | $488.0M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资CTLPVCEL
| Q4 25 | $53.0M | $137.5M | ||
| Q3 25 | $55.0M | $135.4M | ||
| Q2 25 | $51.1M | $116.9M | ||
| Q1 25 | $46.3M | $112.9M | ||
| Q4 24 | $27.7M | $116.2M | ||
| Q3 24 | $33.1M | $101.7M | ||
| Q2 24 | $58.9M | $102.5M | ||
| Q1 24 | $50.2M | $110.6M |
总债务CTLPVCEL
| Q4 25 | $37.7M | — | ||
| Q3 25 | $38.3M | — | ||
| Q2 25 | $38.7M | — | ||
| Q1 25 | $39.2M | — | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $37.3M | — | ||
| Q2 24 | $37.5M | — | ||
| Q1 24 | $38.1M | — |
股东权益CTLPVCEL
| Q4 25 | $252.5M | $354.6M | ||
| Q3 25 | $251.8M | $321.9M | ||
| Q2 25 | $251.0M | $306.8M | ||
| Q1 25 | $240.7M | $295.5M | ||
| Q4 24 | $190.1M | $292.0M | ||
| Q3 24 | $186.2M | $257.5M | ||
| Q2 24 | $181.7M | $243.0M | ||
| Q1 24 | $178.8M | $233.9M |
总资产CTLPVCEL
| Q4 25 | $381.9M | $488.0M | ||
| Q3 25 | $389.5M | $453.3M | ||
| Q2 25 | $381.9M | $435.6M | ||
| Q1 25 | $370.5M | $424.6M | ||
| Q4 24 | $303.0M | $432.7M | ||
| Q3 24 | $312.1M | $390.4M | ||
| Q2 24 | $335.6M | $376.8M | ||
| Q1 24 | $319.9M | $356.7M |
负债/权益比CTLPVCEL
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.1M | $15.0M |
| 自由现金流经营现金流 - 资本支出 | $-614.0K | $12.8M |
| 自由现金流率自由现金流/营收 | -0.8% | 13.8% |
| 资本支出强度资本支出/营收 | 4.8% | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.65× |
| 过去12个月自由现金流最近4个季度 | $25.8M | $24.7M |
8季度趋势，按日历期对齐
经营现金流CTLPVCEL
| Q4 25 | $3.1M | $15.0M | ||
| Q3 25 | $7.0M | $22.1M | ||
| Q2 25 | $9.4M | $8.2M | ||
| Q1 25 | $22.4M | $6.6M | ||
| Q4 24 | $522.0K | $22.2M | ||
| Q3 24 | $-12.0M | $10.2M | ||
| Q2 24 | $14.3M | $18.5M | ||
| Q1 24 | $14.7M | $7.2M |
自由现金流CTLPVCEL
| Q4 25 | $-614.0K | $12.8M | ||
| Q3 25 | $3.5M | $19.5M | ||
| Q2 25 | $4.3M | $81.0K | ||
| Q1 25 | $18.6M | $-7.6M | ||
| Q4 24 | $-3.8M | $8.5M | ||
| Q3 24 | $-15.8M | $-9.2M | ||
| Q2 24 | $8.5M | $1.8M | ||
| Q1 24 | $11.4M | $-6.8M |
自由现金流率CTLPVCEL
| Q4 25 | -0.8% | 13.8% | ||
| Q3 25 | 4.4% | 28.8% | ||
| Q2 25 | 5.3% | 0.1% | ||
| Q1 25 | 24.6% | -14.5% | ||
| Q4 24 | -5.1% | 11.2% | ||
| Q3 24 | -22.3% | -15.9% | ||
| Q2 24 | 11.7% | 3.4% | ||
| Q1 24 | 16.9% | -13.3% |
资本支出强度CTLPVCEL
| Q4 25 | 4.8% | 2.4% | ||
| Q3 25 | 4.2% | 3.9% | ||
| Q2 25 | 6.2% | 12.9% | ||
| Q1 25 | 5.1% | 27.0% | ||
| Q4 24 | 5.8% | 18.3% | ||
| Q3 24 | 5.4% | 33.5% | ||
| Q2 24 | 7.9% | 31.8% | ||
| Q1 24 | 4.8% | 27.3% |
现金转化率CTLPVCEL
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | 1.38× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.10× | 1.12× | ||
| Q3 24 | -3.36× | — | ||
| Q2 24 | 6.47× | — | ||
| Q1 24 | 3.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTLP
| Transaction Processing | $47.9M | 61% |
| Subscription Revenue | $21.8M | 28% |
| Products | $9.0M | 11% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
